Analyst firms · Morgan Stanley · NDAQ
Morgan Stanley NDAQ price target and rating history
Nasdaq Inc. (NDAQ) · Finance
Morgan Stanley rates Nasdaq Inc. (NDAQ) Overweight with a $110 price target, as of its latest action on Nov 20, 2025. It has published 11 rating actions on NDAQ since July 2021, including 2 upgrades and 2 downgrades. Across 4 firms with a NDAQ price target in the last 12 months, the median target is $103. Morgan Stanley's $110 is 7% above that.
- Current rating
- Overweight
- Price target
- $110
- Median target, all firms
- $103
- Actions on NDAQ
- 11
Morgan Stanley price target on NDAQ
Every Morgan Stanley rating on NDAQ
- Nov 20, 2025
- Apr 8, 2025
- Apr 9, 2024
- Apr 11, 2023
- Jan 27, 2022
- Jan 14, 2022
- Oct 21, 2021
- Oct 19, 2021
- Oct 8, 2021
- Jul 23, 2021
- Jul 16, 2021
How other firms rate NDAQ
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Erste Group | Buy | Oct 30, 2026 | |
| Wells Fargo | Equal Weight | $100 | Oct 2, 2026 |
| Keefe, Bruyette & Woods | Mkt Perform | $92 | Apr 8, 2026 |
| TD Cowen | Buy | $106 | Feb 26, 2026 |
| Morgan Stanley | Overweight | $110 | Nov 20, 2025 |
Questions about Morgan Stanley and NDAQ
- What is Morgan Stanley's price target for NDAQ?
- Morgan Stanley's latest stated price target for Nasdaq Inc. (NDAQ) is $110, from its action on Nov 20, 2025.
- What is Morgan Stanley's rating on NDAQ?
- Morgan Stanley rates NDAQ Overweight, a bullish rating, as of Nov 20, 2025.
- When did Morgan Stanley last change its view on NDAQ?
- On Nov 20, 2025, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $110.
- How does Morgan Stanley's NDAQ target compare with other analysts?
- Across 4 firms with a NDAQ price target in the last 12 months, the median target is $103. Morgan Stanley's $110 is 7% above that.
More NDAQ rating histories
All Morgan Stanley ratingsNDAQ news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.